Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community samples.
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The present study sought to quantify the generalizability of clinical trial results in individuals with a Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnosis of borderline personality disorder (BPD) to a large representative community sample. Data were derived from the 2004-2005 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a large nationally representative sample of 34,653 adults from the United States population. We applied a standard set of exclusion criteria representative of pharmacological and psychotherapy clinical trials to all adults with a DSM-IV diagnosis of BPD (n = 2,231). Our aim was to assess how many participants with BPD would not fulfill typical eligibility criteria. We found that more than 7 of 10 respondents in a typical pharmacological efficacy trial and more than 5 of 10 participants in a typical psychotherapy efficacy trial would have been excluded by at least 1 criterion. Having a current history of alcohol or drug use disorder and a lifetime history of bipolar disorder explained a large proportion of ineligibility in both pharmacological and psychotherapy efficacy trials. Clinical trials should carefully consider the impact of exclusion criteria on the generalizability of their results. As required by CONSORT guidelines, reporting exclusion rate estimate and reasons of eligibility should be mandatory in both clinical trials and meta-analyses. As treatment trials of borderline personality disorder move from efficacy to effectiveness to better inform clinical practice, the eligibility rate must be increased by imposing less stringent eligibility criteria to allow for more generalizable results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. S., Pulay, A. J., Pickering, R. P., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0404 · Cited by 1,618
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Psychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895
Westen, D., & Morrison, K. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.875 · Cited by 635 · cited 1×
“…et al., 2013; Hoertel, Le Strat, Lavaud, et al., 2013; Licht, 2002; Rabinowitz, Bromet, & Davidson, 2003; Schneider, Olin, Lyness, & Chui, 1997; Westen & Morrison, 2001), pharmacological and psychotherapy treatment trials for borderline personality disorder (BPD) applied strict eligibility…”
Ruan, W. J., Goldstein, R. B., Chou, S. P., Smith, S. M., Saha, T. D., Pickering, R. P., Dawson, D. A., Huang, B., Stinson, F. S., & Grant, B. F. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.001 · Cited by 557
Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1001 · Cited by 479 · cited 2×
“Reliability was fair to good for mood and anxiety disorders ( 0.40–0.60) and other personality disorders ( 0.40–0.67) (Grant et al., 2003; Grant, Stinson, et al., 2004; Grant et al., 2005).”
BackgroundMethodInfluentialWells, K. B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.5 · Cited by 390 · cited 1×
“As a consequence, there has been a call to quantify the generalizability of RCTs results to the broader target population suffering from the disorder under study (Geddes, 2005; Wells, 1999).”
BackgroundNational Trends in Outpatient Psychotherapy
Olfson, M., & Marcus, S. C. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10040570 · Cited by 315 · cited 1×
“(Lundvall, Rajaei, Erlandson, & Kyllerman, 2012; Hoertel, Limosin & Leleu, 2014; Olfson & Marcus, 2010), the percentage of adults taking a psychotropic medication is likely to be high (Verdoux & Begaud, 2004) and might potentially lead to an underestimation of the proportion of patients excluded in…”
BackgroundPharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
The case for practical clinical trials in psychiatry.
March, J. S., Silva, S. G., Compton, S., Shapiro, M., Califf, R., & Krishnan, R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.836 · Cited by 240
Wisniewski, S. R., Rush, A. J., Nierenberg, A. A., Gaynes, B. N., Warden, D., Luther, J. F., McGrath, P. J., Lavori, P. W., Thase, M. E., Fava, M., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071027 · Cited by 223 · cited 1×
“In addition, a previous study (Wisniewski et al., 2009) showed that some exclusion criteria in clinical trials may be predictors of poor treatment outcomes, suggesting that increasing generalizability of results to practice could potentially reduce placebo response and remission rates (decreasing…”
Le Strat, Y., Rehm, J., & Le Foll, B. (2011) · Tobacco Control · doi:10.1136/tc.2010.038703 · Cited by 67
Hoertel, N., Le Strat, Y., Blanco, C., Lavaud, P., & Dubertret, C. (2012) · Depression and Anxiety · doi:10.1002/da.21937 · Cited by 61
Self-citationSani, G., Kotzalidis, G. D., Vöhringer, P., Pucci, D., Simonetti, A., Manfredi, G., Savoja, V., Tamorri, S. M., Mazzarini, L., Pacchiarotti, I., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318287019c · Cited by 27
Cited by
Hasin, D. S., & Grant, B. F. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1088-0 · Cited by 452
Lorenzo-Luaces, L., Johns, E., & Keefe, J. R. (2018) · Journal of Medical Internet Research · doi:10.2196/10113 · Cited by 36
Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder
Blanco, C., Hoertel, N., Franco, S., Olfson, M., He, J.-P., López, S., González-Pinto, A., Limosin, F., & Merikangas, K. R. (2017) · Pediatrics · doi:10.1542/peds.2016-1701 · Cited by 29
“1999;38(3):272–279”
InfluentialSelf-citationPharmacological management of personality disorders: from evidence to practice
Völlm, B., & Cerci, D. (2025) · BJPsych Advances · doi:10.1192/bja.2024.30 · Cited by 4
“In a large community sample with borderline personality disorder (BPD) (Hoertel 2015), it was shown that seven out of ten patients with this diagnosis would not be included in pharmacological trials owing to exclusion criteria.”
Agger, J. L., Schröder, A., Ørnbøl, E., Jensen, J. S., Pedersen, H. F., Fink, P., & Gormsen, L. K. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114474 · Cited by 1
Metadata
- Authors
- Hoertel, N., López, S., Wang, S., González-Pinto, A., Limosin, F., & Blanco, C.
- Venue
- Personality Disorders: Theory, Research, and Treatment
- Published
- 2015-01
- Volume
- 6
- Issue
- 1
- Pages
- 81-87
- ISSN
- 1949-2715 (ISSN-L)
- 1949-2723
- OpenAlex
- W2328956903
- Cited by
- 23
- References
- 14
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.